448 related articles for article (PubMed ID: 27288767)
1. Anti-thyroid antibodies and thyroid function in neuromyelitis optica spectrum disorders.
Wang X; Yi H; Liu J; Li M; Mao ZF; Xu L; Peng FH
J Neurol Sci; 2016 Jul; 366():3-7. PubMed ID: 27288767
[TBL] [Abstract][Full Text] [Related]
2. Positive antithyroid antibody predicts severity of neuromyelitis optica spectrum disorder in children.
Huo L; Wang H; Yuan Y; Gao J; Liu X
Mult Scler Relat Disord; 2022 Jan; 57():103425. PubMed ID: 34906814
[TBL] [Abstract][Full Text] [Related]
3. Low T3 syndrome in neuromyelitis optica spectrum disorder: Associations with disease activity and disability.
Cho EB; Min JH; Cho HJ; Seok JM; Lee HL; Shin HY; Lee KH; Kim BJ
J Neurol Sci; 2016 Nov; 370():214-218. PubMed ID: 27772762
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea.
Seok JM; Cho HJ; Ahn SW; Cho EB; Park MS; Joo IS; Shin HY; Kim SY; Kim BJ; Kim JK; Cho JY; Huh SY; Kwon O; Lee KH; Kim BJ; Min JH
Mult Scler; 2017 Nov; 23(13):1748-1756. PubMed ID: 28058965
[TBL] [Abstract][Full Text] [Related]
5. Anti-thyroid antibodies and cerebrospinal fluid findings in neuromyelitis optica spectrum disorders.
Li H; Dai Y; Wu AM; Sun X; Lin Y; Lv K; Lu Z
J Neuroimmunol; 2015 Apr; 281():38-43. PubMed ID: 25867466
[TBL] [Abstract][Full Text] [Related]
6. Correlations among disability, anti-AQP4 antibody status and prognosis in the spinal cord involved patients with NMOSD.
Hsu JL; Liao MF; Chang KH; Cheng MY; Ro LS
BMC Neurol; 2021 Apr; 21(1):153. PubMed ID: 33836682
[TBL] [Abstract][Full Text] [Related]
7. Eye movement abnormalities in AQP4-IgG positive neuromyelitis optica spectrum disorder.
Sun H; Cui S; Gao F; You Q; Li Y; Wang J; Zhang X
J Neurol Sci; 2018 Jan; 384():91-95. PubMed ID: 29249386
[TBL] [Abstract][Full Text] [Related]
8. Autoantibody to MOG suggests two distinct clinical subtypes of NMOSD.
Yan Y; Li Y; Fu Y; Yang L; Su L; Shi K; Li M; Liu Q; Borazanci A; Liu Y; He Y; Bennett JL; Vollmer TL; Shi FD
Sci China Life Sci; 2016 Dec; 59(12):1270-1281. PubMed ID: 26920678
[TBL] [Abstract][Full Text] [Related]
9. Short transverse myelitis in Chinese patients with neuromyelitis optica spectrum disorders.
Hu H; You X; Ye J
Mult Scler Relat Disord; 2018 Apr; 21():78-83. PubMed ID: 29499441
[TBL] [Abstract][Full Text] [Related]
10. Comparison of clinical characteristics between neuromyelitis optica spectrum disorders with and without spinal cord atrophy.
Wang Y; Wu A; Chen X; Zhang L; Lin Y; Sun S; Cai W; Zhang B; Kang Z; Qiu W; Hu X; Lu Z
BMC Neurol; 2014 Dec; 14():246. PubMed ID: 25526927
[TBL] [Abstract][Full Text] [Related]
11. Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands.
van Pelt ED; Wong YY; Ketelslegers IA; Hamann D; Hintzen RQ
Eur J Neurol; 2016 Mar; 23(3):580-7. PubMed ID: 26593750
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of anti-SSA/Ro antibody in Neuromyelitis optica spectrum disorders.
Lin L; Hang H; Zhang J; Lu J; Chen D; Shi J
Mult Scler Relat Disord; 2022 Feb; 58():103494. PubMed ID: 35051897
[TBL] [Abstract][Full Text] [Related]
13. Spinal cord involvement by atrophy and associations with disability are different between multiple sclerosis and neuromyelitis optica spectrum disorder.
Nakamura Y; Liu Z; Fukumoto S; Shinoda K; Sakoda A; Matsushita T; Hayashida S; Isobe N; Watanabe M; Hiwatashi A; Yamasaki R; Kira JI
Eur J Neurol; 2020 Jan; 27(1):92-99. PubMed ID: 31304648
[TBL] [Abstract][Full Text] [Related]
14. Expression and Clinical Correlation Analysis Between Repulsive Guidance Molecule a and Neuromyelitis Optica Spectrum Disorders.
Tang J; Zeng X; Yang J; Zhang L; Li H; Chen R; Tang S; Luo Y; Qin X; Feng J
Front Immunol; 2022; 13():766099. PubMed ID: 35185873
[TBL] [Abstract][Full Text] [Related]
15. Spinal cord atrophy in neuromyelitis optica spectrum disorders.
Wang Y; Wang Y; Tan S; Lu Z
Mult Scler Relat Disord; 2016 Jul; 8():9-10. PubMed ID: 27456868
[TBL] [Abstract][Full Text] [Related]
16. Neuromyelitis optica spectrum disorders with and without connective tissue disorders.
Yang CS; Zhang QX; Chang SH; Zhang LJ; Li LM; Qi Y; Wang J; Sun ZH; Zhangning N; Yang L; Shi FD
BMC Neurol; 2018 Oct; 18(1):177. PubMed ID: 30355349
[TBL] [Abstract][Full Text] [Related]
17. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.
Flanagan EP; Weinshenker BG; Krecke KN; Lennon VA; Lucchinetti CF; McKeon A; Wingerchuk DM; Shuster EA; Jiao Y; Horta ES; Pittock SJ
JAMA Neurol; 2015 Jan; 72(1):81-7. PubMed ID: 25384099
[TBL] [Abstract][Full Text] [Related]
18. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
Kitley J; Waters P; Woodhall M; Leite MI; Murchison A; George J; Küker W; Chandratre S; Vincent A; Palace J
JAMA Neurol; 2014 Mar; 71(3):276-83. PubMed ID: 24425068
[TBL] [Abstract][Full Text] [Related]
19. Seronegative neuromyelitis optica spectrum disorder patients diagnosed using new diagnostic criteria.
Uzawa A; Mori M; Uchida T; Masuda H; Ohtani R; Kuwabara S
Mult Scler; 2016 Sep; 22(10):1371-5. PubMed ID: 26552730
[TBL] [Abstract][Full Text] [Related]
20. Long-term disability in neuromyelitis optica spectrum disorder with a history of myelitis is associated with age at onset, delay in diagnosis/preventive treatment, MRI lesion length and presence of symptomatic brain lesions.
Mealy MA; Mossburg SE; Kim SH; Messina S; Borisow N; Lopez-Gonzalez R; Ospina JP; Scheel M; Yeshokumar AK; Awad A; Leite MI; Arango JJ; Paul F; Palace J; Kim HJ; Levy M
Mult Scler Relat Disord; 2019 Feb; 28():64-68. PubMed ID: 30554040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]